{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:58:13Z","timestamp":1791406693672,"version":"4.3.3"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.ajog.2015.09.066","type":"journal-article","created":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T05:25:42Z","timestamp":1443677142000},"page":"108.e1-108.e14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":149,"title":["Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study"],"prefix":"10.1016","volume":"214","author":[{"given":"Mimi Y.","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill P.","family":"Buyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta M.","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarosh","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl A.","family":"Laskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Petri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Lockshin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa R.","family":"Sammaritano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Ware","family":"Branch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Flint","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan T.","family":"Merrill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary D.","family":"Stephenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Ananth","family":"Karumanchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane E.","family":"Salmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2015.09.066_bib1","first-page":"650","article-title":"Fetal outcome of lupus pregnancy: a retrospective case-control study of the Hopkins Lupus Cohort","volume":"20","author":"Petri","year":"1993","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.ajog.2015.09.066_bib2","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/rheumatology\/39.9.1014","article-title":"Outcome of lupus pregnancy: a controlled study","volume":"39","author":"Georgiou","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ajog.2015.09.066_bib3","doi-asserted-by":"crossref","first-page":"127.e1","DOI":"10.1016\/j.ajog.2008.03.012","article-title":"A\u00a0national study of the complications of lupus in pregnancy","volume":"199","author":"Clowse","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.09.066_bib4","doi-asserted-by":"crossref","DOI":"10.7326\/M14-2235","article-title":"Predictors of pregnancy outcome in a prospective, multiethnic cohort of lupus patients: a cohort study","volume":"163","author":"Buyon","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajog.2015.09.066_bib5","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.placenta.2005.12.006","article-title":"The uterine spiral arteries in human pregnancy: facts and controversies","volume":"27","author":"Pijnenborg","year":"2006","journal-title":"Placenta"},{"issue":"Suppl","key":"10.1016\/j.ajog.2015.09.066_bib6","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.placenta.2008.11.009","article-title":"The two stage model of preeclampsia: variations on the theme","volume":"30","author":"Roberts","year":"2009","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2015.09.066_bib7","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.placenta.2009.02.009","article-title":"Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy","volume":"30","author":"Burton","year":"2009","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2015.09.066_bib8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1146\/annurev-pathol-121808-102149","article-title":"Pathogenesis of preeclampsia","volume":"5","author":"Young","year":"2010","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.ajog.2015.09.066_bib9","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1172\/JCI119388","article-title":"Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome?","volume":"99","author":"Zhou","year":"1997","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ajog.2015.09.066_bib10","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ajog.2015.09.066_bib11","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2015.09.066_bib12","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1084\/jem.20072041","article-title":"VEGF and TGF-beta are required for the maintenance of the choroid plexus and ependyma","volume":"205","author":"Maharaj","year":"2008","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.ajog.2015.09.066_bib13","doi-asserted-by":"crossref","first-page":"396.e1","DOI":"10.1016\/j.ajog.2006.12.024","article-title":"The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice","volume":"196","author":"Lu","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.09.066_bib14","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMoa055352","article-title":"Soluble endoglin and other circulating antiangiogenic factors in preeclampsia","volume":"355","author":"Levine","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2015.09.066_bib15","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3109\/14767050902994754","article-title":"A\u00a0prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia","volume":"22","author":"Kusanovic","year":"2009","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2015.09.066_bib16","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1161\/CIRCULATIONAHA.109.895458","article-title":"Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension","volume":"122","author":"Noori","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ajog.2015.09.066_bib17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/AOG.0000000000000367","article-title":"Characterization of the soluble fms-like tyrosine kinase-1 to placental growth factor ratio in pregnancies complicated by fetal growth restriction","volume":"124","author":"Herraiz","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.09.066_bib18","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1093\/aje\/kwq373","article-title":"Angiogenic factors in maternal circulation and the risk of severe fetal growth restriction","volume":"173","author":"Asvold","year":"2011","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajog.2015.09.066_bib19","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.3109\/14767051003681121","article-title":"An imbalance between angiogenic and anti-angiogenic factors precedes fetal death in a subset of patients: results of a longitudinal study","volume":"23","author":"Romero","year":"2010","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2015.09.066_bib20","doi-asserted-by":"crossref","first-page":"310.e1","DOI":"10.1016\/j.ajog.2013.01.017","article-title":"Evidence of an imbalance of angiogenic\/antiangiogenic factors in massive perivillous fibrin deposition (maternal floor infarction): a placental lesion associated with recurrent miscarriage and fetal death","volume":"208","author":"Whitten","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.09.066_bib21","doi-asserted-by":"crossref","first-page":"287.e1","DOI":"10.1016\/j.ajog.2013.01.016","article-title":"Maternal plasma concentrations of angiogenic\/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia","volume":"208","author":"Chaiworapongsa","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.09.066_bib22","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajog.2015.09.066_bib23","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1002\/art.34402","article-title":"Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies","volume":"64","author":"Lockshin","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajog.2015.09.066_bib24","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.ajog.2015.09.066_bib25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/00006250-200201000-00028","article-title":"Diagnosis and management of preeclampsia and eclampsia. ACOG Practice bulletin no. 33, January 2002","volume":"99","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.09.066_bib26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/14767050701830480","volume":"21","author":"Romero","year":"2008","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2015.09.066_bib27","series-title":"Statistical methods for rates and proportions","author":"Fleiss","year":"2003"},{"key":"10.1016\/j.ajog.2015.09.066_bib28","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/j.ajog.2015.09.066_bib29","doi-asserted-by":"crossref","first-page":"W1","DOI":"10.7326\/M14-0698","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): explanation and elaboration","volume":"162","author":"Moons","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajog.2015.09.066_bib30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-11-13","article-title":"One statistical test is sufficient for assessing new predictive markers","volume":"11","author":"Vickers","year":"2011","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.ajog.2015.09.066_bib31","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s11926-013-0403-6","article-title":"Pregnancy morbidity in antiphospholipid syndrome: what is the impact of treatment?","volume":"16","author":"de Jesus","year":"2014","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.ajog.2015.09.066_bib32","doi-asserted-by":"crossref","first-page":"e85258","DOI":"10.1371\/journal.pone.0085258","article-title":"Low-molecular weight heparin increases circulating sFlt-1 levels and enhances urinary elimination","volume":"9","author":"Hagmann","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2015.09.066_bib33","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1161\/ATVBAHA.111.237784","article-title":"Heparin strongly induces soluble fms-like tyrosine kinase 1 release in\u00a0vivo and in\u00a0vitro\u2013brief report","volume":"31","author":"Searle","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajog.2015.09.066_bib34","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.placenta.2015.01.004","article-title":"Aspirin inhibits expression of sFLT1 from human cytotrophoblasts induced by hypoxia, via cyclo-oxygenase 1","volume":"36","author":"Li","year":"2015","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2015.09.066_bib35","first-page":"631","article-title":"Soluble Fms-like tyrosine kinase associated with preeclampsia in pregnancy in systemic lupus erythematosus","volume":"35","author":"Qazi","year":"2008","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.ajog.2015.09.066_bib36","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1182\/blood-2013-01-478958","article-title":"Meta-analysis of low-molecular-weight heparin to prevent recurrent placenta-mediated pregnancy complications","volume":"123","author":"Rodger","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ajog.2015.09.066_bib37","doi-asserted-by":"crossref","first-page":"819","DOI":"10.7326\/M14-1884","article-title":"US Preventive Services Task Force. Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: US Preventive Services Task Force recommendation statement","volume":"161","author":"LeFevre","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajog.2015.09.066_bib38","first-page":"920467","article-title":"Aspirin for prevention of preeclampsia in lupus pregnancy","volume":"2014","author":"Schramm","year":"2014","journal-title":"Autoimmune Dis"},{"key":"10.1016\/j.ajog.2015.09.066_bib39","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1172\/JCI200318817","article-title":"Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome","volume":"112","author":"Girardi","year":"2003","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ajog.2015.09.066_bib40","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1084\/jem.20061022","article-title":"Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction","volume":"203","author":"Girardi","year":"2006","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.ajog.2015.09.066_bib41","doi-asserted-by":"crossref","first-page":"485","DOI":"10.4049\/jimmunol.174.1.485","article-title":"TNF-alpha is a critical effector and a target for therapy in antiphospholipid antibody-induced pregnancy loss","volume":"174","author":"Berman","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ajog.2015.09.066_bib42","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/art.39029","article-title":"Interferon-alpha and angiogenic dysregulation in pregnant lupus patients who develop preeclampsia","volume":"67","author":"Andrade","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ajog.2015.09.066_bib43","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.4049\/jimmunol.1001782","article-title":"The detrimental effects of IFN-alpha on vasculogenesis in lupus are mediated by repression of IL-1 pathways: potential role in atherogenesis and renal vascular rarefaction","volume":"185","author":"Thacker","year":"2010","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ajog.2015.09.066_bib44","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.4049\/jimmunol.1402220","article-title":"Prevention of defective placentation and pregnancy loss by blocking innate immune pathways in a syngeneic model of placental insufficiency","volume":"195","author":"Gelber","year":"2015","journal-title":"J\u00a0Immunol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937815011059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937815011059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:05:48Z","timestamp":1757588748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937815011059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0002937815011059"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2015.09.066","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2015.09.066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}